English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Identification of novel Cyclooxygenase-2-dependent genes in Helicobacter pylori infection in vivo

MPS-Authors
/persons/resource/persons82201

Walduck,  Anna
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82206

Weber,  Matthias
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82226

Wunder,  Christian
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons81958

Juettner,  Stefan
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82047

Meyer,  Thomas F.
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82073

Naumann,  Michael
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons81939

Hoecker,  Michael
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Locator
There are no locators available
Fulltext (public)

Mol_Cancer_2009_8_22.pdf
(Publisher version), 668KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Walduck, A., Weber, M., Wunder, C., Juettner, S., Stolte, M., Vieth, M., et al. (2009). Identification of novel Cyclooxygenase-2-dependent genes in Helicobacter pylori infection in vivo. Molecular Cancer, 8: 22.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-C10D-F
Abstract
Background: Helicobacter pylori is a crucial determining factor in the pathogenesis of benign and neoplastic gastric diseases. Cyclooxygenase-2 (Cox-2) is the inducible key enzyme of arachidonic acid metabolism and is a central mediator in inflammation and cancer. Expression of the Cox-2 gene is up-regulated in the gastric mucosa during H. pylori infection but the pathobiological consequences of this enhanced Cox-2 expression are not yet characterized. The aim of this study was to identify novel genes down-stream of Cox-2 in an in vivo model, thereby identifying potential targets for the study of the role of Cox-2 in H. pylori pathogenesis and the initiation of pre-cancerous changes. Results: Gene expression profiles in the gastric mucosa of mice treated with a specific Cox-2 inhibitor (NS398) or vehicle were analysed at different time points (6, 13 and 19 wk) after H. pylori infection. H. pylori infection affected the expression of 385 genes over the experimental period, including regulators of gastric physiology, proliferation, apoptosis and mucosal defence. Under conditions of Cox-2 inhibition, 160 target genes were regulated as a result of H. pylori infection. The Cox-2 dependent subset included those influencing gastric physiology (Gastrin, Galr1), epithelial barrier function (Tjp1, connexin45, Aqp5), inflammation (Icam1), apoptosis (Clu) and proliferation (Gdf3, Igf2). Treatment with NS398 alone caused differential expression of 140 genes, 97 of which were unique, indicating that these genes are regulated under conditions of basal Cox-2 expression. Conclusion: This study has identified a panel of novel Cox-2 dependent genes influenced under both normal and the inflammatory conditions induced by H. pylori infection. These data provide important new links between Cox-2 and inflammatory processes, epithelial repair and integrity.